Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PET and prostate cancer.

G Sanz1, J Rioja, J J Zudaire

  • 1Hospital Santos Reyes, Dpto. de Urologia, Aranda de Duero, Burgos, Burgos 09400, Spain. gosanz@airtel.net

World Journal of Urology
|October 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria.

Leukemia research·2022
Same author

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.

ESMO open·2022
Same author

Variation of enterohepatic circulation observed with <sup>75</sup>SeHCAT images in the first three hours. Scintigraphic patterns and analysis of their association with the diagnosis of bile acid malabsorption.

Revista espanola de medicina nuclear e imagen molecular·2021
Same author

Diagnostic value of quantitative SPECT/CT in assessing active sacroiliitis in patients with axial spondylarthritis and/or inflammatory low back pain.

Anales del sistema sanitario de Navarra·2021
Same author

Variation of enterohepatic circulation through the image with <sup>75</sup>SeHCAT in the first 3 hours. Scintigraphic patterns and análisis of its association with the diagnosis of bile acid malabsorption.

Revista espanola de medicina nuclear e imagen molecular·2021
Same author

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.

Leukemia·2020

Positron emission tomography (PET) using 11C choline shows promise for diagnosing prostate cancer by identifying metabolic activity and improving tumor staging, localization, and relapse detection. This technique offers advantages over traditional methods for prostate carcinoma diagnosis.

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiology

Background:

  • Current prostate cancer diagnostic techniques face limitations in tumor staging, volume quantification, and early relapse detection.
  • Positron emission tomography (PET) offers a metabolic imaging approach, utilizing radioactive tracers to detect increased tumor activity.
  • Fluorine-18 fluorodeoxyglucose (FDG) PET has shown limitations in prostate cancer diagnosis due to renal excretion and uptake in benign conditions.

Purpose of the Study:

  • To evaluate the potential of novel PET tracers for improving prostate cancer diagnosis.
  • To address the limitations of existing diagnostic methods in staging, localization, and relapse detection of prostate cancer.
  • To investigate the efficacy of 11C choline PET-CT in overcoming diagnostic challenges in prostate carcinoma.

Main Methods:

Related Experiment Videos

  • Review of diagnostic imaging techniques for prostate cancer, including PET.
  • Exploration of radiotracers like 18F-FDG and 11C choline for PET imaging.
  • Focus on the combined PET-CT technique for enhanced diagnostic accuracy.

Main Results:

  • 18F-FDG PET studies yielded contradictory results due to issues with renal elimination and uptake in non-malignant conditions.
  • 11C choline demonstrates higher affinity for prostate cancer, enabling better differentiation of malignant from benign processes.
  • 11C choline PET-CT shows promising results in addressing key diagnostic challenges in prostate cancer, including staging, localization, and relapse identification.

Conclusions:

  • 11C choline PET-CT represents a significant advancement in prostate cancer diagnostics.
  • This technique enhances diagnostic sensitivity and aids in precise localization of the disease.
  • PET-CT with 11C choline offers a promising solution for the unresolved issues in prostate carcinoma diagnosis.